Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Siltuximab Treatment Increases Hemoglobin (Hb) Levels: Preliminary Results From a Prospective Phase 1 Study In Refractory Solid Tumors

R. Kurzrock, E. Angévin, S. Cohen, J. Van Laethem, B. Rijnbeek, J. Vermeulen, B. Tromp, W. Li, M. Reddy, M. Cornfeld, J. Tabernero

Blood (2010) 116 (21): 5150.

https://doi.org/10.1182/blood.V116.21.5150.5150

Published: 2010

Journal Articles

Mycosis fungoides and Sezary syndrome [see comments]

E Diamandidou, PR Cohen, R Kurzrock

Blood (1996) 88 (7): 2385–2409.

https://doi.org/10.1182/blood.V88.7.2385.bloodjournal8872385

Published: 1996

Journal Articles

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

E Estey, PF Thall, K Mehta, M Rosenblum, T Jr Brewer, V Simmons, F Cabanillas, R Kurzrock, G Lopez-Berestein

Blood (1996) 87 (9): 3650–3654.

https://doi.org/10.1182/blood.V87.9.3650.bloodjournal8793650

Published: 1996

Journal Articles

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]

JE Cortes, M Talpaz, F Cabanillas, JF Seymour, R Kurzrock

Blood (1995) 85 (9): 2516–2520.

https://doi.org/10.1182/blood.V85.9.2516.bloodjournal8592516

Published: 1995

Journal Articles

Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates

M Wetzler, R Kurzrock, Z Estrov, H Kantarjian, H Gisslinger, MP Underbrink, M Talpaz

Blood (1994) 84 (9): 3142–3147.

https://doi.org/10.1182/blood.V84.9.3142.3142

Published: 1994

Journal Articles

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

S O'Brien, R Kurzrock, M Duvic, H Kantarjian, S Stass, LE Robertson, E Estey, S Pierce, MJ Keating

Blood (1994) 84 (3): 733–738.

https://doi.org/10.1182/blood.V84.3.733.733

Published: 1994

Journal Articles

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

JF Seymour, R Kurzrock, EJ Freireich, EH Estey

Blood (1994) 83 (10): 2906–2911.

https://doi.org/10.1182/blood.V83.10.2906.2906

Published: 1994

Journal Articles

Chronic myelogenous leukemia: a concise update

HM Kantarjian, A Deisseroth, R Kurzrock, Z Estrov, M Talpaz

Blood (1993) 82 (3): 691–703.

https://doi.org/10.1182/blood.V82.3.691.691

Published: 1993

Journal Articles

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors

Z Estrov, R Kurzrock, E Estey, M Wetzler, A Ferrajoli, D Harris, M Blake, JU Gutterman, M Talpaz

Blood (1992) 79 (8): 1938–1945.

https://doi.org/10.1182/blood.V79.8.1938.1938

Published: 1992

Journal Articles

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

EH Estey, R Kurzrock, HM Kantarjian, SM O'Brien, KB McCredie, M Beran, C Koller, MJ Keating, C Hirsch-Ginsberg, YO Huh

Blood (1992) 79 (4): 882–887.

https://doi.org/10.1182/blood.V79.4.882.882

Published: 1992

Journal Articles

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

HM Kantarjian, M Talpaz, K Dhingra, E Estey, MJ Keating, S Ku, J Trujillo, Y Huh, S Stass, R Kurzrock

Blood (1991) 78 (9): 2411–2418.

https://doi.org/10.1182/blood.V78.9.2411.2411

Published: 1991

Journal Articles

Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression

M Wetzler, R Kurzrock, DG Lowe, H Kantarjian, JU Gutterman, M Talpaz

Blood (1991) 78 (9): 2400–2406.

https://doi.org/10.1182/blood.V78.9.2400.2400

Published: 1991

Journal Articles

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity

Z Estrov, R Kurzrock, M Wetzler, H Kantarjian, M Blake, D Harris, JU Gutterman, M Talpaz

Blood (1991) 78 (6): 1476–1484.

https://doi.org/10.1182/blood.V78.6.1476.1476

Published: 1991

Journal Articles

Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias

K Dhingra, M Talpaz, MG Riggs, PS Eastman, T Zipf, S Ku, R Kurzrock

Blood (1991) 77 (2): 238–242.

https://doi.org/10.1182/blood.V77.2.238.238

Published: 1991

Journal Articles

Fludarabine therapy in macroglobulinemic lymphoma

HM Kantarjian, R Alexanian, CA Koller, R Kurzrock, MJ Keating

Blood (1990) 75 (10): 1928–1931.

https://doi.org/10.1182/blood.V75.10.1928.1928

Published: 1990

Journal Articles

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

EH Estey, D Dixon, HM Kantarjian, MJ Keating, K McCredie, GP Bodey, R Kurzrock, M Talpaz, EJ Freireich, AB Deisseroth

Blood (1990) 75 (9): 1766–1769.

https://doi.org/10.1182/blood.V75.9.1766.1766

Published: 1990

Journal Articles

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course

R Kurzrock, HM Kantarjian, M Shtalrid, JU Gutterman, M Talpaz

Blood (1990) 75 (2): 445–452.

https://doi.org/10.1182/blood.V75.2.445.445

Published: 1990

Journal Articles

Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia

M Shtalrid, M Talpaz, R Kurzrock, H Kantarjian, J Trujillo, J Gutterman, G Yoffe, M Blick

Blood (1988) 72 (2): 485–490.

https://doi.org/10.1182/blood.V72.2.485.485

Published: 1988

Journal Articles

Expression of c-abl in Philadelphia-positive acute myelogenous leukemia

R Kurzrock, M Shtalrid, M Talpaz, WS Kloetzer, JU Gutterman

Blood (1987) 70 (5): 1584–1588.

https://doi.org/10.1182/blood.V70.5.1584.1584

Published: 1987

Journal Articles

Therapy of chronic myelogenous leukemia with recombinant interferon- gamma

R Kurzrock, M Talpaz, H Kantarjian, R Walters, S Saks, JM Trujillo, JU Gutterman

Blood (1987) 70 (4): 943–947.

https://doi.org/10.1182/blood.V70.4.943.943

Published: 1987

NARROW

Siltuximab Treatment Increases Hemoglobin (Hb) Levels: Preliminary Results From a Prospective Phase 1 Study In Refractory Solid Tumors

Mycosis fungoides and Sezary syndrome [see comments]

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]

Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

Chronic myelogenous leukemia: a concise update

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia

Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity

Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemias

Fludarabine therapy in macroglobulinemic lymphoma

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course

Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia

Expression of c-abl in Philadelphia-positive acute myelogenous leukemia

Therapy of chronic myelogenous leukemia with recombinant interferon- gamma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only